MedTrace Logo

Combined Package of Interventions for Environmental Enteropathy

NCT02253095 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2015-06-03

No results posted yet for this study

Summary

Randomized, double-blind, placebo controlled trial of a combined intervention of zinc, albendazole, and multiple micronutrients in improving environmental enteropathy in Malawian children.

Conditions

  • Environmental Enteropathy

Interventions

DRUG

Albendazole

DIETARY_SUPPLEMENT

Zinc

DIETARY_SUPPLEMENT

Multiple Micronutrient Supplement

DRUG

Placebo

Sponsors & Collaborators

  • University of Malawi

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Mark J Manary, MD · Washington University in St. Louis; University of Malawi

  • Chrissie Thakwalakwa, PhD · University of Malawi

  • Indi Trehan, MD MPH DTM&H · Washington University in St. Louis; University of Malawi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
35 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02253095 on ClinicalTrials.gov